Brief: Intensity Therapeutics Regains Compliance With Nasdaq's Minimum Bid Price Requirement
06/03/2026 12:48
March 6 (Reuters) - Intensity Therapeutics Inc INTS.O: INTENSITY THERAPEUTICS REGAINS COMPLIANCE WITH NASDAQ'S MINIMUM BID PRICE REQUIREMENT Source text: ID:nPn1SxNwVa Further company coverage: INTS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intensity Therapeutics
See all newsIntensity Therapeutics Q2 net loss widens as R&D costs rise
Brief: Intensity Therapeutics Q2 Operating Income USD -3.084 Million
Intensity Therapeutics Q1 net loss narrows on lower R&D costs
Brief: Intensity Therapeutics Q1 Operating Income USD -2.526 Million
Brief: Intensity Therapeutics Inc - Increases ATM Offering Capacity To $60 Million On March 23, 2026 - SEC Filing